Niki BiosolutionsNIKI

13F holders, Q4 2025 (December 31)
7holders +4
5new positions
1sold out
1famous investor
$1.06avg. 13F price*

At the end of Q4 2025, 7 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, up 4 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($123K), Two Sigma Investments, LP ($18K) and Morgan Stanley ($14K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Niki Biosolutions Inc.
Filed as
APTORUM GROUP LIMITED (Q4 2025)
CUSIP
G6096M122
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 5Q1 2024Q2 2024: 4Q2 2024Q3 2024: 2Q3 2024Q4 2024: 4Q4 2024Q1 2025: 8Q1 2025Q2 2025: 4Q2 2025Q3 2025: 3Q3 2025Q4 2025: 7Q4 2025Q1 2026: 8Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions5$158K
Exits1$560

All 13F filers, Q3 2025 → Q4 2025: 148,942 shares bought and 277 shares sold, net +148,665 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

Citadel Advisors 0.00% New 115,584 $123K
Two Sigma Investments, LP 0.00% New 17,411 $18K
Morgan Stanley 0.00% New 13,300 $14K
Osaic Holdings, Inc. 0.00% No change 5,501 $6K
UBS Group AG 0.00% New 2,247 $2K
BNP Paribas Financial Markets 0.00% New 400 $424
SBI Securities Co., Ltd. 0.00% No change 7 $7

"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.